Total Payments
$6,535
2024 Payments
$500.63
Companies
35
Transactions
393
Medicare Patients
1,290
Medicare Billing
$298,797
Payment Breakdown by Category
Food & Beverage$6,529 (99.9%)
Education$6.35 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,529 | 392 | 99.9% |
| Education | $6.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,435 | 114 | $0 (2024) |
| GlaxoSmithKline, LLC. | $902.69 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $445.79 | 20 | $0 (2020) |
| Lilly USA, LLC | $400.92 | 23 | $0 (2024) |
| Allergan, Inc. | $387.62 | 22 | $0 (2020) |
| Novo Nordisk Inc | $363.01 | 28 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $319.95 | 19 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $239.53 | 8 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $216.77 | 6 | $0 (2022) |
| Daiichi Sankyo Inc. | $187.35 | 19 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $500.63 | 34 | ABBVIE INC. ($264.24) |
| 2023 | $735.28 | 60 | AbbVie Inc. ($405.11) |
| 2022 | $987.45 | 56 | ABBVIE INC. ($312.01) |
| 2021 | $1,224 | 68 | AbbVie Inc. ($453.21) |
| 2020 | $1,180 | 73 | Allergan, Inc. ($322.94) |
| 2019 | $359.37 | 21 | GlaxoSmithKline, LLC. ($151.09) |
| 2018 | $637.99 | 31 | GlaxoSmithKline, LLC. ($180.31) |
| 2017 | $910.33 | 50 | AstraZeneca Pharmaceuticals LP ($254.36) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | IBSA Pharma Inc. | Tirosint (Drug), Licart | Food and Beverage | Cash or cash equivalent | $21.34 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.80 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Bone Health | ||||||
| 09/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | ALK-Abello, Inc | Odactra (Drug), Grastek, Ragwitek | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Allergy and Immunology | ||||||
| 06/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: RESPIRATORY | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.12 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Immunology | ||||||
| 05/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 323 | 847 | $186,509 | $79,279 |
| 2022 | 7 | 315 | 812 | $173,636 | $74,268 |
| 2021 | 8 | 337 | 934 | $181,499 | $81,628 |
| 2020 | 8 | 315 | 848 | $126,621 | $63,623 |
Total Patients
1,290
Total Services
3,441
Medicare Billing
$298,797
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 66 | 256 | $76,032 | $33,708 | 44.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 300 | $66,300 | $26,544 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 132 | $20,064 | $8,355 | 41.6% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2023 | 22 | 84 | $14,868 | $5,600 | 37.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $8,225 | $4,684 | 56.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 20 | 21 | $735.00 | $228.00 | 31.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 19 | $285.00 | $159.60 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 429 | $94,809 | $38,900 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 89 | $26,433 | $12,302 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 121 | $18,392 | $7,854 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $11,045 | $6,403 | 58.0% |
| 98929 | Osteopathic manipulative treatment, 9-10 body regions | Office | 2022 | 25 | 91 | $16,107 | $5,989 | 37.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $4,642 | $1,780 | 38.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 24 | $2,208 | $1,040 | 47.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 434 | $95,914 | $41,998 | 43.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 215 | $32,680 | $15,293 | 46.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 35 | 61 | $18,117 | $8,440 | 46.6% |
| 98929 | Osteopathic manipulative treatment to 9-10 body regions | Office | 2021 | 22 | 103 | $18,231 | $7,178 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 44 | 44 | $10,340 | $6,112 | 59.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 17 | 32 | $2,944 | $1,331 | 45.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 11 | 34 | $2,888 | $1,139 | 39.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 11 | 11 | $385.00 | $137.17 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 100 | 389 | $62,641 | $31,742 | 50.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 85 | 207 | $26,173 | $12,054 | 46.1% |
| 98929 | Osteopathic manipulative treatment to 9-10 body regions | Office | 2020 | 19 | 93 | $11,436 | $6,718 | 58.7% |
About Dr. Patrica Schechter, D.O
Dr. Patrica Schechter, D.O is a Family Medicine healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386641306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrica Schechter, D.O has received a total of $6,535 in payments from pharmaceutical and medical device companies, with $500.63 received in 2024. These payments were reported across 393 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,529).
As a Medicare-enrolled provider, Schechter has provided services to 1,290 Medicare beneficiaries, totaling 3,441 services with total Medicare billing of $298,797. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Atascadero, CA
- Active Since 07/05/2005
- Last Updated 07/05/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386641306
Products in Payments
- VRAYLAR (Drug) $758.43
- UBRELVY (Drug) $676.75
- NURTEC ODT (Drug) $487.64
- TRELEGY ELLIPTA (Drug) $428.60
- QULIPTA (Drug) $307.33
- FARXIGA (Drug) $304.40
- ANORO (Drug) $298.68
- TRINTELLIX (Drug) $226.61
- EMGALITY (Drug) $187.44
- MOUNJARO (Drug) $177.04
- Movantik (Drug) $169.60
- Ozempic (Drug) $161.98
- Tymlos (Biological) $159.97
- Aimovig (Biological) $145.90
- SOLIQUA 100/33 (Biological) $124.42
- BEVESPI AEROSPHERE (Drug) $123.20
- Trintellix (Drug) $112.13
- Osphena (Drug) $108.02
- ENTRESTO (Drug) $103.40
- BREO (Drug) $70.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Atascadero
Dr. Simon Hamid, Md, MD
Family Medicine — Payments: $1,373
Family Medicine $1,373
Dr. Donah Bulosan, M.d, M.D
Family Medicine — Payments: $1,123
Family Medicine $1,123
Dr. Stephen Ripple, D.o, D.O
Family Medicine — Payments: $608.56
Family Medicine $608.56
Dr. Karen Roberts, Md, MD
Family Medicine — Payments: $527.68
Family Medicine $527.68
Susan Smith, Md, MD
Family Medicine — Payments: $311.33
Family Medicine $311.33
Hani Boutros, Md, MD
Family Medicine — Payments: $310.58
Family Medicine $310.58